2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Breast Neoplasms
84
Neoplasm Metastasis
59
Prostatic Neoplasms
57
Leukemia, Myeloid, Acute
57
Melanoma
49
Multiple Myeloma
47
Colorectal Neoplasms
44
Lung Neoplasms
43
Pancreatic Neoplasms
39
Carcinoma, Non-Small-Cell Lung
38
Lymphoma
37
Neoplasms
30
Myelodysplastic Syndromes
30
Leukemia, Lymphocytic, Chronic, B-Cell
30
Squamous Cell Carcinoma of Head and Neck
28
Lymphoma, Large B-Cell, Diffuse
25
Triple Negative Breast Neoplasms
24
Ovarian Neoplasms
24
Burkitt Lymphoma
21
Rectal Neoplasms
20
Lymphoma, Follicular
19
Colonic Neoplasms
19
Uterine Cervical Neoplasms
18
Stomach Neoplasms
18
Sarcoma
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Carcinoma, Renal Cell
18
Lymphoma, Mantle-Cell
17
Glioma
17
Head and Neck Neoplasms
16
Interventions
Imatinib Mesylate
5
ruxolitinib
4
ponatinib
4
nilotinib
4
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
4
Azacitidine
3
fludarabine phosphate
2
fludarabine
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Cyclophosphamide
2
Busulfan
2
Bone Marrow Transplantation
2
spartalizumab
1
sonidegib
1
simtuzumab
1
sabatolimab
1
pembrolizumab
1
ibrutinib
1
bosutinib
1
Zoledronic Acid
1
Watchful Waiting
1
Sertraline
1
SCIO-469
1
Quality of Life
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bone Marrow Diseases
×
Biopsy
×
Clear all
NCT02452983
2022-06-02
SS1
Baylor College of Medicine
Phase 1
Terminated
14 enrolled